›› 2016, Vol. 36 ›› Issue (9): 852-856.

• 综述 • 上一篇    下一篇

天疱疮临床诊疗研究进展

杨丽群,范媛   

  1. 江苏省口腔医院
  • 收稿日期:2016-04-18 修回日期:2016-05-31 出版日期:2016-09-28 发布日期:2016-10-06
  • 通讯作者: 范媛 E-mail:fanyuan65@hotmail.com
  • 基金资助:
    优势学科二期国家自然科学基金资助项目;江苏省高校优势学科建设工程资助项目

Research progress ofthe clinical diagnosis and treatment of pemphigus

Li-Qun YANG1,   

  • Received:2016-04-18 Revised:2016-05-31 Online:2016-09-28 Published:2016-10-06

摘要: 天疱疮(pemphigus)是一类累及皮肤和黏膜的自身免疫性疱病,基本病理变化为棘细胞层松解。患者血清内存在针对桥粒芯蛋白(desmoglein, Dsg)的自身抗体,该抗体是诊断天疱疮的免疫学指标,同时与病情变化相关。糖皮质激素是治疗天疱疮的首选药物,然而如何制定最佳的治疗方案,依赖于一个能准确评估病情严重程度、稳定合理的评分系统。本文将对近年来天疱疮的诊断、病情评分系统以及治疗的研究进展作一报道

关键词: 天疱疮, 诊断, 评分系统, 治疗

Abstract: Pemphigus is an autoimmune bullous disease affecting the skin and mucosa.The basic pathological change is acantholysis. Desmoglein (Dsg) antibodies in the serum of patients is the immunological indicator for the diagnosis of pemphigus and correlates with illness changes. Glucocorticoid is the first choice for treatment.However, how to develop the best therapy relies on a stable and reasonable scoring system with an accurate assessment of disease severity.In this article, we will report the advances in the diagnosis, scoring system and treatment of pemphigus in recent years.

Key words: Pemphigus, Diagnosis, Scoring system, Treatment

中图分类号: